183
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Changes of PI3K/AKT/BCL2 signaling proteins in congenital Giant Nevi: melanocytes contribute to their increased survival and integrity

, , , , &
Pages 359-366 | Received 06 May 2013, Accepted 25 Aug 2013, Published online: 27 Sep 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yuqing Mao, Jianbo Wang, Fujun Yu, Jian Cheng, Huanqing Li, Chuanyong Guo & Xiaoming Fan. (2015) Ghrelin reduces liver impairment in a model of concanavalin A-induced acute hepatitis in mice. Drug Design, Development and Therapy 9, pages 5385-5396.
Read now

Articles from other publishers (10)

Songtao Tan, Haoyue Hu, Xin Xin & Di Wu. (2023) A clinical and biologic review of congenital melanocytic nevi. The Journal of Dermatology.
Crossref
Emmanouil Chousakos, Nikolaos Katsoulas, Nikolaos Kavantzas, Alexandros Stratigos & Andreas C. Lazaris. (2022) The role of dual‐specificity phosphatase 3 in melanocytic oncogenesis. Experimental Dermatology 31:10, pages 1466-1476.
Crossref
Yeon Sook Choi, Tal H. Erlich, Max von Franque, Inbal Rachmin, Jessica L. Flesher, Erik B. Schiferle, Yi Zhang, Marcello Pereira da Silva, Alva Jiang, Allison S. Dobry, Mack Su, Sharon Germana, Sebastian Lacher, Orly Freund, Ezra Feder, Jose L. Cortez, Suyeon Ryu, Tamar Babila Propp, Yedidyah Leo Samuels, Labib R. Zakka, Marjan Azin, Christin E. Burd, Norman E. Sharpless, X. Shirley Liu, Clifford Meyer, William Gerald AustenJr.Jr., Branko Bojovic, Curtis L. CetruloJr.Jr., Martin C. Mihm, Dave S. Hoon, Shadmehr Demehri, Elena B. Hawryluk & David E. Fisher. (2022) Topical therapy for regression and melanoma prevention of congenital giant nevi. Cell 185:12, pages 2071-2085.e12.
Crossref
Boxuan Wei, Jieyu Gu, Ran Duan, Bowen Gao, Min Wu, Shengliang Zhou, Xiaolu Huang & Feng Xie. (2021) Transcriptome Analysis of Large to Giant Congenital Melanocytic Nevus Reveals Cell Cycle Arrest and Immune Evasion: Identifying Potential Targets for Treatment. Journal of Immunology Research 2021, pages 1-16.
Crossref
Yubo Tang, Jie Chen, Jiaqi Li, Yifan Zheng, Xiuxiu Zhong, Shuai Huang, Bin Chen, Baogang Peng, Xuenong Zou & Xiao Chen. (2021) Pristimerin synergistically sensitizes conditionally reprogrammed patient derived-primary hepatocellular carcinoma cells to sorafenib through endoplasmic reticulum stress and ROS generation by modulating Akt/FoxO1/p27kip1 signaling pathway. Phytomedicine 86, pages 153563.
Crossref
Zhaojia Wu, Tong Niu & Wei Xiao. (2019) Uev1A promotes breast cancer cell survival and chemoresistance through the AKT-FOXO1-BIM pathway. Cancer Cell International 19:1.
Crossref
Wenyan Kang, Zhilong Jia, Di Tang, Zhanwei Zhang, Hui Gao, Kunlun He & Qiang Feng. (2019) Fusobacterium nucleatum Facilitates Apoptosis, ROS Generation, and Inflammatory Cytokine Production by Activating AKT/MAPK and NF- κ B Signaling Pathways in Human Gingival Fibroblasts . Oxidative Medicine and Cellular Longevity 2019, pages 1-22.
Crossref
Maojun Zhou, Qi Zhang, Jinfeng Zhao, Mingmei Liao, Sailan Wen & Manyi Yang. (2017) Phosphorylation of Bcl-2 plays an important role in glycochenodeoxycholate-induced survival and chemoresistance in HCC. Oncology Reports.
Crossref
Ho-Sung Lee, Myeong-Jin Goh, Junil Kim, Tae-Jun Choi, Hae Kwang Lee, Yong Joo Na & Kwang-Hyun Cho. (2015) A systems-biological study on the identification of safe and effective molecular targets for the reduction of ultraviolet B-induced skin pigmentation. Scientific Reports 5:1.
Crossref
Lan Wang, Jun-Ling Liu, Liang Yu, Xiang-Xia Liu, Hong-Mei Wu, Fang-Yong Lei, Shu Wu & Xi Wang. (2015) Downregulated miR-495 Inhibits the G1-S Phase Transition by Targeting Bmi-1 in Breast Cancer. Medicine 94:21, pages e718.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.